Novo Nordisk A/S (NYSE:NVO)
$ 134.66 1.74 (1.31%) Market Cap: 599.89 Bil Enterprise Value: 602.45 Bil PE Ratio: 46.60 PB Ratio: 41.56 GF Score: 92/100

Q1 2022 Novo Nordisk A/S Earnings Call Transcript

Apr 29, 2022 / 11:00AM GMT
Release Date Price: $57 (+3.46%)
Operator

Hello, and welcome to the Novo Nordisk Q1 2022 Results Call. (Operator Instructions) Today, I'm pleased to present Lars Fruergaard Jørgensen. Please go ahead with your meeting.

Lars Fruergaard Jorgensen;S;President
Novo Nordisk A;CEO & Member of Management Board

/- -

Thank you very much. Welcome to this Novo Nordisk Earnings call for the first 3 months of 2022 and outlook for the year. This call follows the early announcement and raise guidance published earlier today. Due to securities regulations, we had to advance the release that was originally scheduled for Wednesday next week.

My name is Lars Fruergaard Jørgensen, and I'm the CEO of Novo Nordisk. With me today, I have Executive Vice President and Head of Commercial Strategy and Corporate Affairs, Camilla Sylvest; Executive Vice President and Head of North America Operations, Doug Langa; Executive Vice President and Head of Development, Martin Holst Lange; and finally, Chief Financial Officer, Karsten Knudsen. All of us will be available for the Q&amp

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot